The 10-second takeaway
For the quarter ended March 31 (Q3), Clorox beat expectations on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue increased and GAAP earnings per share dropped.
Margins shrank across the board.
Clorox reported revenue of $1.40 billion. The 12 analysts polled by S&P Capital IQ expected to see revenue of $1.35 billion on the same basis. GAAP reported sales were 7.4% higher than the prior-year quarter's $1.30 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.02. The 15 earnings estimates compiled by S&P Capital IQ predicted $1.04 per share. GAAP EPS of $0.99 for Q3 were 9.2% lower than the prior-year quarter's $1.09 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 42.3%, 180 basis points worse than the prior-year quarter. Operating margin was 16.1%, 220 basis points worse than the prior-year quarter. Net margin was 9.3%, 230 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $1.53 billion. On the bottom line, the average EPS estimate is $1.28.
Next year's average estimate for revenue is $5.41 billion. The average EPS estimate is $4.08.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 823 members out of 859 rating the stock outperform, and 36 members rating it underperform. Among 258 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 254 give Clorox a green thumbs-up, and four give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Clorox is hold, with an average price target of $69.64.
Can your retirement portfolio provide you with enough income to last? You'll need more than Clorox. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.
- Add Clorox to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool owns shares of Clorox. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.